Skip to main content
Erschienen in: Pediatric Radiology 11/2011

01.11.2011 | Pictorial Essay

Medication neurotoxicity in children

verfasst von: Ramesh S. Iyer, Apeksha Chaturvedi, Sumit Pruthi, Paritosh C. Khanna, Gisele E. Ishak

Erschienen in: Pediatric Radiology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Medication neurotoxicity may have a variety of imaging manifestations in children. In this pictorial essay, we review the two most common brain injury patterns, posterior reversible encephalopathy syndrome (PRES) and acute toxic leukoencephalopathy (ATL). Proposed etiologies, salient features on neurological imaging, and methods for differentiating these entities and their implications will be discussed. Certain agents do not fall into these two broad patterns but instead characteristically involve central structures. We individually review several medications and their respective neurotoxic appearances including methotrexate, cyclosporine A, tacrolimus, metronidazole and vigabatrin. Diagnosis of medication neurotoxicity may be achieved by the combination of new-onset neurological deficits, recent initiation of a new therapy agent and distinctive findings on magnetic resonance imaging. Clinical and radiological improvement and/or resolution are frequently observed after the agent is discontinued.
Literatur
1.
Zurück zum Zitat Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef
2.
Zurück zum Zitat Ugurel MS, Hayakawa M (2005) Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome. Eur J Radiol 53:441–449PubMedCrossRef Ugurel MS, Hayakawa M (2005) Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome. Eur J Radiol 53:441–449PubMedCrossRef
3.
Zurück zum Zitat Hefzy HM, Bartynski WS, Boardman JF et al (2009) Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR 30:1371–1379PubMedCrossRef Hefzy HM, Bartynski WS, Boardman JF et al (2009) Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR 30:1371–1379PubMedCrossRef
4.
Zurück zum Zitat Incecik F, Hergüner MO, Altunbasak S et al (2009) Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurol India 57:475–478PubMedCrossRef Incecik F, Hergüner MO, Altunbasak S et al (2009) Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurol India 57:475–478PubMedCrossRef
5.
Zurück zum Zitat McKinney AM, Short J, Truwit CL et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR 189:904–912PubMedCrossRef McKinney AM, Short J, Truwit CL et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR 189:904–912PubMedCrossRef
6.
Zurück zum Zitat Casey SO, Sampaio RC, Michel E et al (2000) Posterior reversible encephalopathy syndrome: utility of fluid attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR 21:1199–1206PubMed Casey SO, Sampaio RC, Michel E et al (2000) Posterior reversible encephalopathy syndrome: utility of fluid attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR 21:1199–1206PubMed
7.
Zurück zum Zitat Casey SO, Truwit CL (2000) Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR 21:243–245PubMed Casey SO, Truwit CL (2000) Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR 21:243–245PubMed
8.
Zurück zum Zitat Mukherjee P, McKinstry RC (2001) Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor imaging. Radiology 219:756–765PubMed Mukherjee P, McKinstry RC (2001) Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor imaging. Radiology 219:756–765PubMed
9.
Zurück zum Zitat Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR 23:1038–1048PubMed Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR 23:1038–1048PubMed
10.
Zurück zum Zitat Schwartz RB, Feske SK, Polak JF et al (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217:371–376PubMed Schwartz RB, Feske SK, Polak JF et al (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217:371–376PubMed
11.
Zurück zum Zitat Provenzale JM, Petrella JR, Cruz LC Jr et al (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR 22:1455–1461PubMed Provenzale JM, Petrella JR, Cruz LC Jr et al (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR 22:1455–1461PubMed
12.
Zurück zum Zitat Tamaki K, Sadoshima S, Baumbach GL et al (1984) Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy. Hypertension 6(2 Pt 2):I75–I81PubMed Tamaki K, Sadoshima S, Baumbach GL et al (1984) Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy. Hypertension 6(2 Pt 2):I75–I81PubMed
13.
14.
Zurück zum Zitat Ito T, Sakai T, Inagawa S et al (1995) MR angiography of cerebral vasospasm in preeclampsia. AJNR 16:1344–1346PubMed Ito T, Sakai T, Inagawa S et al (1995) MR angiography of cerebral vasospasm in preeclampsia. AJNR 16:1344–1346PubMed
15.
Zurück zum Zitat McKinney AM, Kieffer SA, Paylor RT et al (2009) Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR 193:192–206PubMedCrossRef McKinney AM, Kieffer SA, Paylor RT et al (2009) Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR 193:192–206PubMedCrossRef
16.
Zurück zum Zitat Beitinjaneh A, McKinney AM, Cao Q et al (2011) Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 17:300–308PubMedCrossRef Beitinjaneh A, McKinney AM, Cao Q et al (2011) Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 17:300–308PubMedCrossRef
17.
Zurück zum Zitat Filley CM (1999) Toxic leukoencephalopathy. Clin Neuropharmacol 22:249–260PubMed Filley CM (1999) Toxic leukoencephalopathy. Clin Neuropharmacol 22:249–260PubMed
19.
Zurück zum Zitat Sandoval C, Kutscher M, Jayabose S et al (2003) Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR 24:1887–1890PubMed Sandoval C, Kutscher M, Jayabose S et al (2003) Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR 24:1887–1890PubMed
20.
Zurück zum Zitat Rollins N, Winick N, Bash R et al (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR 25:1688–1695PubMed Rollins N, Winick N, Bash R et al (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR 25:1688–1695PubMed
21.
Zurück zum Zitat Shibutani M, Okeda R (1989) Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 78:291–300PubMedCrossRef Shibutani M, Okeda R (1989) Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 78:291–300PubMedCrossRef
22.
Zurück zum Zitat Akiba T, Okeda R, Tajima T (1996) Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol 92:8–13PubMedCrossRef Akiba T, Okeda R, Tajima T (1996) Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol 92:8–13PubMedCrossRef
23.
Zurück zum Zitat Okeda R, Shibutani M, Matsuo T et al (1990) Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine. Acta Neuropathol 81:66–73PubMedCrossRef Okeda R, Shibutani M, Matsuo T et al (1990) Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine. Acta Neuropathol 81:66–73PubMedCrossRef
24.
Zurück zum Zitat Fisher MJ, Khademian ZP, Simon EM et al (2005) Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR 26:1686–1689PubMed Fisher MJ, Khademian ZP, Simon EM et al (2005) Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR 26:1686–1689PubMed
25.
Zurück zum Zitat Chessels JM, Cox TC, Kendall B et al (1990) Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child 65:416–422CrossRef Chessels JM, Cox TC, Kendall B et al (1990) Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child 65:416–422CrossRef
26.
Zurück zum Zitat Jaffe N, Takaue Y, Anzai T et al (1985) Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 56:1356–1360PubMedCrossRef Jaffe N, Takaue Y, Anzai T et al (1985) Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 56:1356–1360PubMedCrossRef
27.
Zurück zum Zitat Gowan GM, Herrington JD, Simonetta AB (2002) Methotrexate induced toxic leukoencephalopathy. Pharmacotherapy 22:1183–1187PubMedCrossRef Gowan GM, Herrington JD, Simonetta AB (2002) Methotrexate induced toxic leukoencephalopathy. Pharmacotherapy 22:1183–1187PubMedCrossRef
28.
Zurück zum Zitat Matsumoto K, Takahashi S, Sato A et al (1995) Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy: an MR analysis. Int J Radiat Oncol Biol Phys 32:913–918PubMedCrossRef Matsumoto K, Takahashi S, Sato A et al (1995) Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy: an MR analysis. Int J Radiat Oncol Biol Phys 32:913–918PubMedCrossRef
29.
Zurück zum Zitat Lien HH, Blomlie V, Saeter G et al (1991) Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 179:547–550PubMed Lien HH, Blomlie V, Saeter G et al (1991) Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 179:547–550PubMed
30.
Zurück zum Zitat Rosencrantz R, Moon A, Raynes H et al (2001) Cyclosporine-induced neurotoxicity during treatment of Crohn’s disease: lack of correlation with previously reported risk factors. Am J Gastroenterol 92:2778–2782CrossRef Rosencrantz R, Moon A, Raynes H et al (2001) Cyclosporine-induced neurotoxicity during treatment of Crohn’s disease: lack of correlation with previously reported risk factors. Am J Gastroenterol 92:2778–2782CrossRef
31.
Zurück zum Zitat Trullemans F, Grignard F, Van Camp B et al (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogenic bone marrow transplantation. Eur J Haematol 67:94–99PubMedCrossRef Trullemans F, Grignard F, Van Camp B et al (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogenic bone marrow transplantation. Eur J Haematol 67:94–99PubMedCrossRef
32.
Zurück zum Zitat Bartynski WS, Zeigler Z, Spearman MP et al (2001) Etiology of cortical and white matter lesions in cyclosporine-A and FK-506 neurotoxicity. AJNR 22:1901–1914PubMed Bartynski WS, Zeigler Z, Spearman MP et al (2001) Etiology of cortical and white matter lesions in cyclosporine-A and FK-506 neurotoxicity. AJNR 22:1901–1914PubMed
33.
Zurück zum Zitat Lucey MR, Kolars JC, Merion RM et al (1990) Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 335:11–15PubMedCrossRef Lucey MR, Kolars JC, Merion RM et al (1990) Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 335:11–15PubMedCrossRef
34.
Zurück zum Zitat Reece DE, Frei-Lahr DA, Shephard JD et al (1991) Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8:393–401PubMed Reece DE, Frei-Lahr DA, Shephard JD et al (1991) Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8:393–401PubMed
35.
Zurück zum Zitat Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346PubMedCrossRef Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346PubMedCrossRef
36.
Zurück zum Zitat Schwartz RB, Bravo SM, Klufas RA et al (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR 165:627–631PubMed Schwartz RB, Bravo SM, Klufas RA et al (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR 165:627–631PubMed
37.
Zurück zum Zitat Appignani BA, Bhadelia RA, Blacklow SC et al (1996) Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR 166:683–688PubMed Appignani BA, Bhadelia RA, Blacklow SC et al (1996) Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR 166:683–688PubMed
38.
Zurück zum Zitat Lacaille F, Hertz-Pannier L, Nassogne MC (2004) Magnetic resonance imaging for the diagnosis of acute leukoencephalopathy in children treated with tacrolimus. Neuropediatrics 35:130–133PubMedCrossRef Lacaille F, Hertz-Pannier L, Nassogne MC (2004) Magnetic resonance imaging for the diagnosis of acute leukoencephalopathy in children treated with tacrolimus. Neuropediatrics 35:130–133PubMedCrossRef
39.
Zurück zum Zitat Ahn KF, Lee JW, Hahn ST et al (2003) Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 76:916–919PubMedCrossRef Ahn KF, Lee JW, Hahn ST et al (2003) Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 76:916–919PubMedCrossRef
40.
Zurück zum Zitat Freeman CD, Klutman NE, Lamp KC (1997) Metronidazole: a therapeutic review and update. Drugs 54:679–708PubMedCrossRef Freeman CD, Klutman NE, Lamp KC (1997) Metronidazole: a therapeutic review and update. Drugs 54:679–708PubMedCrossRef
41.
Zurück zum Zitat Frytak S, Moertel CH, Childs DS (1978) Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med 88:361–362PubMed Frytak S, Moertel CH, Childs DS (1978) Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med 88:361–362PubMed
42.
Zurück zum Zitat Kim E, Na DG, Kim EY et al (2007) MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR 28:1652–1658PubMedCrossRef Kim E, Na DG, Kim EY et al (2007) MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR 28:1652–1658PubMedCrossRef
43.
Zurück zum Zitat Heaney CJ, Campeau NG, Lindell EP (2003) MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR 24:1615–1617PubMed Heaney CJ, Campeau NG, Lindell EP (2003) MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR 24:1615–1617PubMed
44.
Zurück zum Zitat Ahmed A, Loes DJ, Bressler EL (1995) Reversible resonance imaging findings in metronidazole-induced encephalopathy. Neurology 45:588–589PubMed Ahmed A, Loes DJ, Bressler EL (1995) Reversible resonance imaging findings in metronidazole-induced encephalopathy. Neurology 45:588–589PubMed
45.
Zurück zum Zitat Cecil KM, Halsted MJ, Schapiro M et al (2002) Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr 26:948–951PubMedCrossRef Cecil KM, Halsted MJ, Schapiro M et al (2002) Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr 26:948–951PubMedCrossRef
46.
Zurück zum Zitat McErlean A, Abdalia K, Donoghue V et al (2010) The dentate nucleus in children: normal development and patterns of disease. Pediatr Radiol 40:326–339PubMedCrossRef McErlean A, Abdalia K, Donoghue V et al (2010) The dentate nucleus in children: normal development and patterns of disease. Pediatr Radiol 40:326–339PubMedCrossRef
47.
Zurück zum Zitat Pearl PL, Vezina LG, Saneto RP et al (2009) Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 50:184–194PubMedCrossRef Pearl PL, Vezina LG, Saneto RP et al (2009) Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 50:184–194PubMedCrossRef
48.
Zurück zum Zitat Ben-Ari Y (2006) Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord 8:91–102PubMed Ben-Ari Y (2006) Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord 8:91–102PubMed
49.
Zurück zum Zitat Dracopoulos A, Widjaja E, Raybaud C et al (2010) Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia 51:1297–1304PubMedCrossRef Dracopoulos A, Widjaja E, Raybaud C et al (2010) Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia 51:1297–1304PubMedCrossRef
50.
Zurück zum Zitat Wheless JW, Carmant L, Bebin M et al (2009) Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 50:195–205PubMedCrossRef Wheless JW, Carmant L, Bebin M et al (2009) Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 50:195–205PubMedCrossRef
51.
Zurück zum Zitat Thapa M, Khanna PC (2010) Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis. Pediatr Radiol 48(Suppl 1):S153CrossRef Thapa M, Khanna PC (2010) Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis. Pediatr Radiol 48(Suppl 1):S153CrossRef
Metadaten
Titel
Medication neurotoxicity in children
verfasst von
Ramesh S. Iyer
Apeksha Chaturvedi
Sumit Pruthi
Paritosh C. Khanna
Gisele E. Ishak
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Pediatric Radiology / Ausgabe 11/2011
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-011-2191-3

Weitere Artikel der Ausgabe 11/2011

Pediatric Radiology 11/2011 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.